An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.
Several professionals stated the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or prison.
Service Response and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the service secure and investing in enhancing compliance measures.
Digital Trading Activities
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, positive testimonials and detailed instructions for preparing or administering at residence.
Within minutes of entering one community, a seller shared WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.
Product Details and Pricing
Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for the messaging service said it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already seen patients harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant medical dangers”.
